Navigation Links
Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients

PALO ALTO, Calif.--(BUSINESS WIRE)--Apr 12, 2007 - Affymax, Inc. (Nasdaq:AFFY) today announced that results available from its Phase 2 clinical trial of Hematide(TM) dosed monthly in dialysis patients were presented this week at the National Kidney Foundation (NKF) 2007 Spring Clinical Meeting. The results from this maintenance-switch trial in patients previously treated with three-times weekly Epoetin Alfa (EPO) demonstrated that mean hemoglobin (Hgb) levels can be maintained at clinically acceptable levels following a switch to once-monthly treatments with Hematide at an appropriate dosing regimen. The data were presented by Anatole Besarab, M.D., adjunct professor of Medicine, Wayne State University and director of Clinical Research at Henry Ford Hospital, Detroit in a poster session at the NKF meeting.

"These data are encouraging and show that patients can be switched from a regimen of EPO three-times weekly to once monthly Hematide in a controlled fashion where hemoglobin levels were maintained within 1 g/dL of baseline at an appropriate dosing regimen," said Dr. Besarab. This is especially important given the growing concerns related to excessive hemoglobin increases due to erythropoiesis stimulating agent use."

"We believe these data support the once per month dosing of Hematide and warrant further investigation in pivotal clinical studies," added Anne-Marie Duliege, M.D., vice president, Clinical, Medical and Regulatory Affairs at Affymax. "Based on the entire Phase 2 data set and as a result of our end of Phase 2 meetings with the Food and Drug Administration (FDA), we are preparing for Phase 3 clinical trials in patients on dialysis and not on dialysis. We are currently in discussions with the FDA on the design of this Phase 3 program."

The Phase 2 trial, which involved 165 patients, was an open label, multi-dose study conducted to assess safety, pharmacodynamics and pharmacokinetics of
'"/>




Page: 1 2 3

Related medicine technology :

1. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
2. Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:7/30/2015)... 30, 2015 PTC Therapeutics, Inc. (NASDAQ: ... financial results for the second quarter ending June 30, ... fronts across the organization.  We are excited to be ... clinical trial ever conducted with topline results expected in ... Executive Officer, PTC Therapeutics, Inc. "Translarna is now commercially ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
(Date:7/30/2015)... --  Gaumard® Scientific Company today announced that ... operating system to support an entire family of ... users. UNI® version 2.27.21.0 adds enhanced functionality including ... well as improvements to laboratory functions, patient charting ... EtCO 2 .  First launched ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 2Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 3
... RENSSELAER, N.Y., Oct. 26 The Upstate New ... Hudson Mohawk Section of the American Society of ... symposium and exhibition on Wednesday, October 27, 2010 ... Assistant Professor, Rensselaer Polytechnic Institute and Seth Cohen, ...
... 26 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated ... ("PRC"), today announced that it has submitted, jointly ... application to China,s State Food and Drug Administration ...
Cached Medicine Technology:Upstate New York Laboratory Robotics Interest Group (LRIG) to Host Free Symposium and Exhibition 2China Sky One Medical Applies for Production Licenses of 15 New Medical Products 2China Sky One Medical Applies for Production Licenses of 15 New Medical Products 3
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... Paul Zaichik Creates New Tool That Increases Training Capability , World ... new tool called Zejax ( http://www.Zejax.com ), that dramatically increases a person’s training ...
(Date:7/30/2015)... ... July 30, 2015 , ... Using the latest online digital technologies, happiness ... effective ways to prevent and manage major depression. , “Suicide is 100% preventable. The ... fall through the cracks and die needlessly everyday,” says Walker. “I’m out to end ...
(Date:7/30/2015)... ... July 30, 2015 , ... On July 23rd ... in taxpayer money to fund the state’s large prison system, which has amassed largely ... highest rates of incarceration. In light of President Obama’s recent reduction of non violent ...
(Date:7/30/2015)... Dana Point, CA (PRWEB) , ... July 30, 2015 , ... ... the highest honors available, including the very rare “no recommendations.” No recommendations means CARF ... full compliance; this is a notation that less than 3% of all facilities receive. ...
(Date:7/30/2015)... Newark, NJ (PRWEB) , ... July 30, 2015 ... ... New Jersey's State-designated entity on behalf of the New Jersey Department of Health, ... for Health Information Technology, an agency of the U.S. Department of Health and ...
Breaking Medicine News(10 mins):Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2
... that Japan Post Network Co., Ltd., a subsidiary of ... the exclusive provider,of cancer insurance for distribution through the ... one of four separate postal entities that,began operating in ... set forth under laws enacted in 2005. Japan Post ...
... cancer risk test promotes early detection to maximize a ... woman,s chance for survival., EVERGREEN ... be diagnosed with breast cancer, according to,the American Cancer Society. Breast cancer ... is the second leading cause of cancer,death in women, after lung cancer. ...
... SGP ) today announced that it has ... (FTC) regarding its,planned acquisition of Organon BioSciences N.V. ... Organon BioSciences is comprised mainly of Organon, ... business. It also,includes Nobilon, the human vaccine development ...
... Bill Hargis never gave up as he,battled corporate investors as ... the experience taught him about greed and ethics,"isn,t the kind ... and put that education to good use, pulling together an,experienced ... 66," a healthy juice drink for school-aged children. As ...
... Nov. 16 21st Services has created its,first Medical ... is an innovative approach in the life settlement industry. ... enhance the sophistication,of its underwriting model and its life ... made up of physicians from,across the country who are ...
... Springer has signed an agreement with the International Sports ... Previously self-published by the ISEA, Sports Engineering is ... published by Springer will appear in January 2008. , ... engineering and science to sport. The quarterly journal ...
Cached Medicine News:Health News:Aflac Japan To Offer Cancer Insurance Product Through Japan Post 2Health News:Aflac Japan To Offer Cancer Insurance Product Through Japan Post 3Health News:Web Site Helps Women Evaluate Risk of Breast Cancer 2Health News:Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V. 2Health News:Fruit 66 Creator Takes the High Road to Create a Healthy Drink for Students 2Health News:In Progressive Move, 21st Services Forms Independent Medical Advisory Board to Study Longevity, Mortality Risk 2Health News:Springer to publish Sports Engineering 2
... The Criterion Dodeca cell, a component of ... run up to 12 Criterion gels in a ... (13.3 x 8.7 cm) than the traditional mini ... strips to give you the optimal combination of ...
... The Mini-PROTEAN 3 Dodeca cell runs up ... in just 35 minutes. Handcast gels can ... the new Model 485 gradient former and ... variation and improving reproducibility. Alternatively, Ready Gel ...
... The 120 Mini-Vertical Gel System simplifies the ... a mini-PAGE format. It is able to run ... utility. To maximize utility and throughput, the ... 7 cm gels (W x L) at one ...
... The ElectroXpress gel electrophoresis system mirrors a ... high-throughput screening of PCR products to take ... the source (96-well) plate. Loading can be carried ... the first time in the industry two ...
Medicine Products: